ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1999

NADPH Oxidase 4 Regulates the Migration and Invasion of Synoviocytes in Rheumatoid Arthritis Through Pro-angiogenic Factor Secretion

Ha-Reum Lee1, Su-Jin Yoo 2, Chan-Geol Park 2, Jinhyun Kim 2, In Seol Yoo 2 and Seong Wook Kang 2, 1Chungnam National University Hospital,, Daejeon, Republic of Korea, 2Chungnam National University Hospital, Daejeon, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Angiogenesis, rheumatoid arthritis, Rheumatoid arthritis (RA), ROS, synovium and Cell Migration

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocytes (FLS) are key effector cells in the pathogenesis of rheumatoid arthritis (RA) through the increased cell migration, degradation of extracellular matrix, and cartilage destruction. Reactive oxygen species (ROS) also have been known to be involved in the initiation and progression of RA, such as secretion of immunoregulatory and pro-angiogenic factors. Despite the important interrelationship between RA FLS and ROS, the mechanism of interaction and signaling is not clear.

Methods: In this study, the differential expression of six NADPH Oxidase subunits was analyzed after stimulation with recombinant interleukin-17 (IL-17) and tumor necrosis factor-alpha (TNFa) in FLS from RA and osteoarthritis (OA) patients. In particular, NADPH Oxidase 4 (NOX4) was highly increased by cytokine stimulation in RA FLS. So, we investigated whether Nox4 has a critical role in the migration and invasion of synoviocytes in RA. This study was performed according to the recommendations of the Declaration of Helsinki and approved by the Institutional Review Board of Chungnam National University Hospital in Republic of Korea. Synovial tissues were obtained from 5 RA patients (female 4, male 1, average age 55.6 ± 11.8) and 5 OA patients (female 4, male 1, average age 64.8 ± 16.1) who received synovectomy or joint replacement. For detection of ROS, MitoSox (mitochondria specific probe) was used according to the manufacturer′s instructions. The cell migration assay was performed using transwell chamber (8 μm pore) and matrigel coating was added to transwell for the cell invasion assay. The migrated cells were stained with crystal violet and quantified.

Results: After the stimulation with recombinant IL-17 (10 ng/ml) and TNFa (10 ng/ml), the expression of Nox4 mRNA was higher by 8.73 folds in RA FLS compared to OA FLS. Following cytokine stimulation for 24 hours, the level of mitochondria-specific ROS was increased by 2 folds in RA FLS compared to OA. When the cells were treated with various concentrations of Nox4 inhibitor GLX351322 (1, 2.5, or 5 μM) for 1 hour, the level of ROS was significantly decreased in a dose dependent manner. On transwell migration assay, cytokines-stimulated RA FLS showed enhanced migratory ability by 3 folds compared to those without stimulation. Pretreatment with 5 μM of Nox4 inhibitor decreased the movement of RA FLS to the baseline level. The expression of pro-angiogenic factors, vascular endothelial growth factor (VEGF) and granulocyte macrophage colony stimulating factor (GM-CSF), was significantly reduced by Nox4 inhibition.

Conclusion: From these data, we suggest that Nox4 may modulate the migration and invasion of synoviocytes and contribute to progression of RA. Nox4 among NADPH Oxidase subunits can be an attractive therapeutic target of RA.

NADPH Oxidase 4 -NOX4- was the higher expression by cytokine stimulation for 1 hr in RA FLS than OA FLS.

Nox4 inhibition significantly decreased the cytokine-induced-migratory ability than no treatment in RA FLS


Disclosure: H. Lee, None; S. Yoo, None; C. Park, None; J. Kim, None; I. Yoo, None; S. Kang, None.

To cite this abstract in AMA style:

Lee H, Yoo S, Park C, Kim J, Yoo I, Kang S. NADPH Oxidase 4 Regulates the Migration and Invasion of Synoviocytes in Rheumatoid Arthritis Through Pro-angiogenic Factor Secretion [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/nadph-oxidase-4-regulates-the-migration-and-invasion-of-synoviocytes-in-rheumatoid-arthritis-through-pro-angiogenic-factor-secretion/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nadph-oxidase-4-regulates-the-migration-and-invasion-of-synoviocytes-in-rheumatoid-arthritis-through-pro-angiogenic-factor-secretion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology